Cancer-Related Gene Therapy Clinical Trials

作者: Robert J. Korst , Ronald G. Crystal

DOI: 10.1007/978-1-59259-785-7_28

关键词: Cancer researchDNAPopulationCancerRNACellEx vivoBiologyIn vivoGenetic enhancement

摘要: Gene therapy represents a strategy using transfer of genetic information to modify population target cells for therapeutic purposes. The transferred material has typically included double-stranded deoxyribonucleic acid (DNA), but occasionally single-stranded DNA and even ribonucleic (RNA). one the many novel “targeted” antineoplastic treatment approaches with goal inhibit growth tumor spare normal cells. use gene relevant cancer includes in vivo modification tumors or tumor-bearing host, as well ex manipulation cell populations, which are then administered host.

参考文章(82)
William G. Wierda, Mark J. Cantwell, Sandra J. Woods, Laura Z. Rassenti, Charles E. Prussak, Thomas J. Kipps, CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia Blood. ,vol. 96, pp. 2917- 2924 ,(2000) , 10.1182/BLOOD.V96.9.2917
MICHAEL R. BISHOP, JOHN D. JACKSON, STEFANO R. TARANTOLO, BARBARA O'KANE-MURPHY, PATRICK L. IVERSEN, ELIEL BAYEVER, SHANTARAM M. JOSHI, J. GRAHAM SHARP, JENE L. PIERSON, PHYLLIS I. WARKENTIN, JAMES O. ARMITAGE, ANNE KESSINGER, Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome Journal of hematotherapy. ,vol. 6, pp. 441- 446 ,(1997) , 10.1089/SCD.1.1997.6.441
Guy Chung-Faye, Syed Hussain, Peter Searle, Philip I. Murray, David Anderson, Joanna Baddeley, David Ferry, Daniel Palmer, Joanna Clark, Peter A. Harris, David J. Kerr, Mandy Downes, Leonard Seymour, Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. Clinical Cancer Research. ,vol. 7, pp. 2662- 2668 ,(2001)
Franak M. Batliwalla, Barbara A. Bateman, Davide Serrano, Douglas Murray, Stuart Macphail, V. C. Maino, John C. Ansel, Peter K. Gregersen, Cheryl A. Armstrong, A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. Molecular Medicine. ,vol. 4, pp. 783- 794 ,(1998) , 10.1007/BF03401771
Sheryl Redlin-Frazier, Patrice S. Obermiller, Jeffrey T. Holt, Allison R. Hatmaker, David L. Tait, Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability. Clinical Cancer Research. ,vol. 5, pp. 1708- 1714 ,(1999)
M R Bishop, P L Iversen, E Bayever, J G Sharp, T C Greiner, B L Copple, R Ruddon, G Zon, J Spinolo, M Arneson, J O Armitage, A Kessinger, Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. Journal of Clinical Oncology. ,vol. 14, pp. 1320- 1326 ,(1996) , 10.1200/JCO.1996.14.4.1320
C Hesdorffer, J Ayello, M Ward, A Kaubisch, L Vahdat, C Balmaceda, T Garrett, M Fetell, R Reiss, A Bank, K Antman, Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. Journal of Clinical Oncology. ,vol. 16, pp. 165- 172 ,(1998) , 10.1200/JCO.1998.16.1.165
Hardev S. Pandha, Lesley-Ann Martin, Anne Rigg, Helen C. Hurst, Gordon W.H. Stamp, Karol Sikora, Nicholas R. Lemoine, Genetic Prodrug Activation Therapy for Breast Cancer: A Phase I Clinical Trial of erbB-2–Directed Suicide Gene Expression Journal of Clinical Oncology. ,vol. 17, pp. 2180- 2180 ,(1999) , 10.1200/JCO.1999.17.7.2180
Svend O Freytag, Mark Khil, Hans Stricker, James Peabody, Mani Menon, Mariza DePeralta-Venturina, Daniel Nafziger, Jan Pegg, Dell Paielli, Steve Brown, Ken Barton, Mei Lu, Estuardo Aguilar-Cordova, Jae Ho Kim, None, Phase I Study of Replication-competent Adenovirus-mediated Double Suicide Gene Therapy for the Treatment of Locally Recurrent Prostate Cancer Cancer Research. ,vol. 62, pp. 4968- 4976 ,(2002)